Cancer Mission calls for 2026 are open – opportunities to develop impactful solutions for cancer patients

Cancer Mission is a key initiative under the European Union’s Horizon Europe research and innovation programme. Its main objective is to improve the lives of millions by advancing cancer prevention, diagnosis, treatment and quality of life for patients and their families. The calls are now open, and Spinverse health domain experts are ready to evaluate your eligibility for the programme.

The objectives for 2026 focus on making significant progress toward the overarching Mission goal. The mission goal with year 2030 in focus aims to improve the lives of more than 3 million people affected by cancer. Projects looking to be funded should deliver prevention and cure to patients and enable them to live longer and better. This not only affects patients but also their families.

The deadline for proposal submission is 15 September 2026, so this is a perfect time to start planning and preparing for the call.

Key objectives of the Cancer Mission for 2026

• Prevention
• Early detection and diagnosis
• Treatment and care
• Quality of life
• Knowledge sharing and research
• Reducing inequalities.

Seven opportunities available for 2026

Below is a list of the funding opportunities, including a link to the EU Funding & Tenders portal.

• HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers.
• HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research.
• HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care.
• HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients.
• HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
• HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine.
• HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease.

How can Spinverse help you succeed?

If your research is relevant to any of the areas mentioned above, please do not hesitate to contact Spinverse. We  have strong competencies within the cancer mission focus areas and understand your needs and can provide you with

• Guidance in ideation & focus of the project scope to fit the call needs
• Co-ideate project concept with consortium partners
• Support in finding new partners with the right expertise to form the consortium
• Advise throughout the innovation value chain with call-specific details to enrich the value of the proposal
• Help with budgeting
• Help to prepare a winning funding proposal
• Securing success in funding proposals.

Take the first step towards securing your EU funding: Reach out to Spinverse today and let us help you unlock the potential of your project!

Rohit Sood, Senior Director and Team Leader for Health Tech, Ph.D. (Chem), MBA
rohit.sood@spinverse.com
+358 50 530 2863 (Finland)

Tina Verolin, Senior Manager and Team Leader in Sweden, Ph.D. RTTP
tina.verolin@spinverse.com 
+46 73 509 7087 (Sweden)